Information sent to healthcare professionals in January 2010 about the safety of medicines

Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.

A list of letters sent to healthcare professionals in January 2010, to inform of new safety information and advice.

Date issued Product Safety information
15 January 2010 NebuChamber inhalation aid

Re-supply of NebuChamber

Letter for pharmacistsPDF file (opens in new window) (79Kb)
Letter for doctors and other prescribersPDF file (opens in new window) (61Kb)
Accompanying photographsPDF file (opens in new window) (237Kb) 
27 January 2010 Reductil (sibutramine)

Recommendation to suspend licence due to negative balance of risks and benefits
Letter for healthcare professionalsPDF file (opens in new window) (396Kb)
Letter for pharmacists regarding return of stock to wholesalePDF file (opens in new window) (20Kb)

Sibutramine: Suspension of marketing authorisation as risks outweigh benefits

Page last modified: 01 February 2010